|Ultrasonographic median nerve cross-section areas measured by 8-point "inching test" for idiopathic carpal tunnel syndrome: a correlation of nerve conduction study severity and duration of clinical symptoms.|
|Jump to Full Text|
|PMID: 22189264 Owner: NLM Status: Publisher|
|ABSTRACT: BACKGROUND: Incremental palmar stimulation of the median nerve sensory conduction at the wrist, the "inching test", provides an assessment with reference to segments proximal and distal to the entrapment. This study used high-resolution ultrasonography (US) to measure the median nerve's cross-section areas (CSAs) like the "inching test" and to correlate with the nerve conduction study (NCS) severity and duration of carpal tunnel syndrome (CTS). METHODS: Two hundred and twelve (212) "CTS-hands" from 135 CTS patients and 50 asymptomatic hands ("A-hands") from 25 control individuals were enrolled. The median nerve CSAs were measured at the 8-point marked as i4, i3, i2, i1, w, o1, o2, and 03 in inching test. The NCS severities were classified into six groups based on motor and sensory responses (i.e., negative, minimal, mild, moderate, severe, and extreme). Results of US studies were compared in terms of NCS severity and duration of clinical CTS symptoms. RESULTS: There was significantly larger CSA of the NCS negative group of "CTS-hands" than of "A-hands". The cut-off values of the CSAs of the NCS negative CTS group were 12.5 mm2, 11.5 mm2 and 10.1 mm2 at the inlet, wrist crease, and outlet, respectively. Of the 212 "CTS-hands", 32 were NCS negative while 40 had minimal, 43 mild, 85 moderate, 10 severe, and two extreme NCS. The CSAs of "CTS-hands" positively correlated with different NCS severities and with the duration of CTS symptoms. By duration of clinical symptoms, 12 of the 212 "CTS-hands" were in the [less than or equal to]1 month group; 82 in >1 month and [less than or equal to]12 months group, and 118 in >12 months group. In "inching test", segments i4-i3 and i3-i2 were the most common "positive-site". The corresponding CSAs measured at i4 and i3, but not at i2, were significantly larger than those measured at points that were not "positive-site". CONCLUSIONS: Using the 8-point measurement of the median nerve CSA from inlet to outlet similar to the "inching test" has positive correlations with NCS severity and duration of CTS clinical symptoms, and can provide more information on anatomic changes. Combined NCS and US studies using the 8-point measurement may have a higher positive rate than NCS alone for diagnosing CTS.|
|Shu-Fang Chen; Cheng-Hsien Lu; Chi-Ren Huang; Yao-Chung Chuang; Nai-Wen Tsai; Chiung-Chih Chang; Wen-Neng Chang|
Related Documents :
|3712064 - Opportunistic intracranial infection in aids detection by technetium-99m dtpa brain sci...
22496364 - Magnetic resonance and confocal imaging of solute penetration into the lens reveals a z...
11295354 - Assessment of scanner performance and normalization of estimated relaxation rate values.
22865564 - Characterization of microfluidic gas reactors using remote-detection mri and parahydrog...
14969844 - Hepatic volumetry with photoshop in personal computer.
16462214 - The use of computerized image guidance in lumbar disk arthroplasty.
|Type: JOURNAL ARTICLE Date: 2011-12-21|
|Title: BMC medical imaging Volume: 11 ISSN: 1471-2342 ISO Abbreviation: - Publication Date: 2011 Dec|
|Created Date: 2011-12-22 Completed Date: - Revised Date: -|
Medline Journal Info:
|Nlm Unique ID: 100968553 Medline TA: BMC Med Imaging Country: -|
|Languages: ENG Pagination: 22 Citation Subset: -|
|APA/MLA Format Download EndNote Download BibTex|
Journal ID (nlm-ta): BMC Med Imaging
Publisher: BioMed Central
Copyright ©2011 Chen et al. ; licensee BioMed Central Ltd.
Received Day: 30 Month: 6 Year: 2011
Accepted Day: 21 Month: 12 Year: 2011
collection publication date: Year: 2011
Electronic publication date: Day: 21 Month: 12 Year: 2011
Volume: 11First Page: 22 Last Page: 22
Publisher Id: 1471-2342-11-22
PubMed Id: 22189264
|Ultrasonographic median nerve cross-section areas measured by 8-point "inching test" for idiopathic carpal tunnel syndrome: a correlation of nerve conduction study severity and duration of clinical symptoms|
|Shu-Fang Chen12||Email: email@example.com|
|Cheng-Hsien Lu1||Email: firstname.lastname@example.org|
|Chi-Ren Huang1||Email: email@example.com|
|Yao-Chung Chuang1||Email: firstname.lastname@example.org|
|Nai-Wen Tsai1||Email: email@example.com|
|Chiung-Chih Chang12||Email: firstname.lastname@example.org|
|Wen-Neng Chang1||Email: email@example.com|
1Department of Neurology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan
2Department of Biological Science, National Sun Yat-Sen University, Kaohsiung, Taiwan
Carpal tunnel syndrome (CTS) is a common entrapment neuropathy of the median nerve . Currently, nerve conduction study (NCS) is used to confirm the diagnosis and indicate the level of the lesion [2,3]. Among various NCS methods for evaluating CTS, incremental palmar stimulation of the median nerve sensory conduction at the wrist, the so-called "inching test", permits an assessment with reference to nerve segments proximal and distal to the entrapment . Aside from NCS, peripheral nerve ultrasonography (US) is a promising complementary tool [3,5-9]. However, because of different US methods, the measured values of the median nerve in CTS also vary [7-10]. This study introduced an 8-point measurement of the median nerve's cross-sectional area (CSA) from inlet to outlet similar to those performed in the "inching test". The measured CSAs were also compared to NCS severity and duration of CTS symptoms.
This prospective case-control study conducted over a period of three years (2006-2008) enrolled 160 participants and 262 hands. Of the 160 participants, 135 with 212 hands had clinical symptoms of CTS ("CTS-hands") while the other 25 participants of 50 hands were asymptomatic ("A-hands") and acted as controls. Of the 135 symptomatic participants, 105 were women and 30 were men, aged 22-83 years (mean, 52.2 ± 11.7 years). Their body height ranged from 142 to 177 cm (mean, 158 ± 6.3 cm), body weight 40 to 86 kg (mean, 60.7 ± 8.7 kg), and body mass index 17.5 to 35.3 (mean, 24.1 ± 3.4). The basic information of the controls is listed in Table 1. The term "A-hands" was defined as a hand with normal NCS findings and not fulfilling any clinical definition of CTS.
In order to avoid other interfering factors, none of the 160 participants had diabetes mellitus, gout, rheumatoid arthritis, renal or liver disease, abnormal thyroid function, abnormal serum cortisol level, or elevated serum anti-nuclear antibody. None of the participants had a history of previous wrist surgery or fracture, or a history or clinical evidence of neurologic disorders (e.g. ulnar neuropathy, radiculopathy, polyneuropathy, myelopathy, or stroke) that might result in numbness or paresthesia. Participants with a variant of carpal tunnel, such as accessory muscles, bifid median nerve, and persistent median artery were also excluded. None of the female participants were pregnant at the time of the study. The hospital's Ethics Committee approved the study (IRB 100-1390B).
Two physicians (Drs CSF and TNW) previously trained by musculoskeletal radiologists and with more than three years of experience in patients with related disorders, especially those with clinical CTS, performed the US examinations. The clinical symptoms of each individual were recorded and the collected data were fully analyzed.
1. Paresthesia, pain, swelling, weakness, or clumsiness of the hand provoked or worsened by sleep, sustained hand or arm position, or repetitive action of the hand or wrist that is mitigated by a change in posture or by shaking of the hand;
2. Sensory deficits in the median nerve innervated regions of the hand;
3. Motor deficit or hypotrophy of the median nerve innervated thenar muscles; and
4. Positive provocative clinical tests (positive Phalen's maneuver and/or Tinel's sign)
The term "CTS-hand" was defined as criterion 1 and one or more of criteria 2-4 were fulfilled. For comparative analysis, the duration of CTS symptoms was classified into three groups, i.e. ≤1 month, >1 and ≤12 months, and > 12 months.
The NCS was performed for all participants according to the recommended protocol of the American Association of Electrodiagnostic Medicine (AAEM)  using a Nicolet Viking Select system (Nicolet Biomedical Inc. Madison, USA). All tests were done in the same room under similar temperature conditions. Skin temperature was maintained at ≥32°C. As regards NCS, the onset latency, amplitude, distance, and velocity of median, ulnar, and radial motor and sensory nerves were measured. The comparative tests included: 1) median-ulnar sensory conduction between the wrist and ring finger, 2) median sensory nerve conduction comparison between the wrist and palm, 3) median-radial sensory conduction between the wrist and thumb, and 4) antidromic sensory test using 1-cm increments of the median nerve with the wrist crease as the zero reference point extending proximally by 3 cm and distally by 4 cm. In total, eight points (Figure 1) were marked in the subsequent inching test.
The cut-off points used in the NCS were the following: 1) median nerve distal sensory latency <3.4 ms , 2) median nerve distal motor latency over the thenar <4.2 ms , 3) difference between the median and ulnar nerve distal sensory latencies <0.4 ms , 4) trans-carpal median motor conduction velocity <40.6 ms , and 5) antidromic sensory using 1-cm increments of the median nerve <0.4 ms . Based on the NCS results, the CTS hands were categorized into six severity groups : negative, for normal findings on all tests; minimal, for abnormal segmental or comparative tests only; mild, for abnormal digit/wrist sensory nerve conduction velocity and normal distal motor latency; moderate, for abnormal digit/wrist sensory nerve conduction velocity and abnormal distal motor latency; severe, for absence of sensory response and abnormal distal motor latency; and extreme, for the absence of motor and sensory response.
High-resolution US was performed using a scanner with a 12/5-MHz linear array transducer for the carpal tunnel study (Philips HDI 5000; Philips Medical Systems, Bothell, WA, USA) on the same day as the NCS. During the examination, the patient sat in a comfortable position facing the examiner, with the measured forearm resting on the table, the palm supine, and fingers semi-extended in the neutral position . The median nerve was first imaged in a longitudinal scan, placing the US probe at the midline between the radius and ulna with the center of the probe at the distal wrist crease, to obtain an initial general overview of the median nerve. This was then used to assist the examiner in obtaining optimal axial (cross-sectional) images. The transducer was placed directly on the patient's skin with gel.
A transverse scan, keeping the probe directly perpendicular to the long axis of the median nerve in order to ensure that the area measured indeed reflected CSA, was then performed to record the CSA (calculated by continual tracing of the nerve circumference, excluding the hyper-echoic epineurial rim) and elliptical diameters (transverse and antero-posterior). Measurements were conducted from the tunnel inlet of the forearm (i4, i3, i2, i1) to the wrist crease (w) and to the tunnel outlet (o1, o2, o3) (Figure 1).
Data were given as mean ± standard deviation. Subsequent ANOVA analysis followed by Scheffe's multiple comparison procedures were used to calculate the mean values of CSA among different symptom duration groups, NCS types, and inching sites. To evaluate differences in CSA value at the 8-point tested between asymptomatic and CTS hands in the NCS negative group, the Mann-Whitney U test was used for comparison, as a consequence of limited data. Significance was set at p < 0.05 in the ANOVA and p < 0.01 in the Mann-Whitney U tests. The area under the ROC (Receiver Operating Characteristic) curves and the CSA cut-off-values were calculated for the negative NCS CTS hands. The Statistical Package for Social Science (SPSS Inc., version 13.0 for Windows) was used for all statistical analyses.
Based on the NCS severity classification, 32 of the 212 "CTS-hands" were in the negative group, 40 in the minimal group, 43 in the mild group, 85 in the moderate group, 10 in the severe group, and two in the extreme group. If classified according to the duration of clinical symptoms, 12 of the 212 "CTS-hands" were in the ≤1 month group, 82 in >1 month and ≤12 months group, and 118 in >12 months group.
The comparative results revealed significantly larger CSA of the latter group of hands at six points (i4, i3, i2, i1, w, and o3). After comparison of the CSAs under the ROC, the cut-off-values of the significant sites were 12.5 mm2, 11.5 mm2, and 10.1 mm2, respectively (Table 2).
The measured CSAs were compared. The NCS negative group and the mild to extreme NCS severity groups, except the minimal severity group, showed significantly larger CSA (Table 3). Because of limited case numbers, both severe and extreme groups were excluded from subsequent group comparisons; i.e. only the negative, minimal, mild, and moderate groups were included for further analysis. Mean CSAs of these four groups showed that the mean CSAs increased in accordance to severity, from negative to moderate (Figures 2 and 3).
The "positive-site" was defined as conduction delay (>0.4 ms) between the interval of the nearby marks in antidromic sensory test with 1 cm increments of the median nerve at the 8-point marks (Figure 4). Results showed that the most common "positive-site" were i4-i3 and i3-i2 (Table 4). The comparative results showed that CSAs corresponding to the "positive site" at i4-i3 were significantly larger than the CSAs of intervals that were not "positive-site" (Table 5). The CSAs measured at i2 did not show significant difference between the positive and the non-positive sites.
The comparative results showed that CSAs of the "CTS-hands" with symptom duration >1 month and ≤12 months, and >12 months were significantly larger than the CSAs of "A-hands". The difference between the CSAs of the "A-hands" and the "CTS-hands" with symptom duration > 1 month was not significant. The "CTS-hands" with >12 months duration had significantly larger CSA than the "CTS-hands" with <1 month duration (Table 6).
For CTS evaluation, several kinds of NCS measurement methods are used for confirmation. As to which measurement method is optimum remains the subject of, long-term debates [1-6,10-20]. In the meantime, although NCS in CTS diagnosis is highly specific , 10-25% of cases are unrecognized by classic NCS depending on the disease severity and the type of NCS technique used [2,21-23]. Thus, "CTS-hands" with a negative NCS poses a diagnostic challenge when using electrophysiologic study alone for confirmation.
In this study, 15.3% (32/212) of "CTS-hands" are NCS negative. This incidence rate is consistent with those of previous reports [2,21-23]. With the 8-point CSA measurement, there are significant differences on several levels between the "A-hands" and NCS negative "CTS-hands". Most of the significant enlargements are located at the inlet (Table 2). It is known that in patients with a clinical diagnosis of CTS, the accuracy of US is similar to that of EMG but is probably preferable because it is painless, easily accessible, and favored by patients . The findings of the present study further strengthen the importance of the complementary role of US in confirming the diagnosis of idiopathic CTS in the NCS negative group. This is also noted in a study of US correlation of CTS in NCS negative "CTS-hands" reported by Rahmani et al. . Therefore, US can be recommended as a useful technique in diagnosing CTS patients when NCS results are not confirmatory in patients suspected of having median neuropathy. The present study also posits the following cut-off values of CSA for CTS confirmation: 12.5 mm2 at the tunnel inlet, 11.5 mm2 at the wrist crease, and 10.1 mm2 at the tunnel outlet.
Except for the NCS minimal group, all of the other groups of "CTS-hands" (from mild to extreme) have significant differences in CSA measurement when compared to that of the NCS negative group (Table 3 and Figures 2 and 3) and a positive correlation with the severities of NCS findings. Although some insignificant enlargements detected in CSA measurement are shown by inter-group comparison (Tables 2 and 3), the present study demonstrates that slower NCS means a larger CSA by US study.
As shown in Table 3 and Figures 2 and 3, CSAs measured at the 8-point of the NCS minimal group are all larger than those of the NCS negative group, but this difference is not statistically significant. This insignificance can be explained partly by the trivial difference in NCS and measured CSAs in these two groups of "CTS-hands". However, this study does not offer enough evidence to sufficiently explain the difference. Further large-scale study is needed for better delineation of the US findings between the NCS negative and NCS minimal groups. Nevertheless, with a measurement of CSA at the 8-point, US remains an important complementary tool for confirming clinical CTS.
As shown in Table 4, the segments between i4 and i3, and i3 and i2 are the most frequent "positive sites", and their respective CSAs are larger than those measured at "non-positive sites" (Table 5). This suggests a positive correlation in NCS severities and measured areas of CSA in the CTS study, a correlation also noted in other studies [10,20,25,26]. The present study (Tables 4 and 5) also reveals that most of the "positive sites" detected in the "inching test" involve the distal part (i2-14) of the inlet, and the CSA measured at i2 is the smallest. These show that the area around i2 is the most possible site of nerve entrapment in idiopathic CTS, which may provide additional guidance for a more precise location for treatment.
As shown in Table 6, there is a positive correlation between the measured CSA with the symptom duration of clinical idiopathic CTS such that the longer the duration of symptoms correlated to larger measured CSA. This finding has not been previously reported. Nonetheless, US provides reproducible median nerve measurements . As such, it can be used to assess changes in median nerve characteristics during follow-up studies of idiopathic CTS.
This study has several limitations. First, although 212 "CTS-hands" were included for examination, further large-scale study is warranted for a more even distribution of the case number in the different sub-groups of "CTS-hands". Second, the limitations of accuracy in inching techniques need to be taken into consideration. This limitation is also noted in other studies [28,29]. Third, there is difficulty in accurately obtaining a chronology of the length of symptom duration. Fourth, there is a lack of using neuroimaging studies such as computed tomography and/or magnetic resonance imaging to test the accuracy of CSA measurement at varying levels and to delineate the local change of carpal tunnel. Fifth, besides CSA measurement, there are other useful, additional measurements of the median nerve with US such as the measurement of width and circumference of the wrist . In this study we did not perform these additional measurements for CSA correlation. Lastly, there is a discrepancy of median nerve length between the conventional surface measurement and US measurement .
More than 15% of "CTS-hands" have negative NCS. The 8-point measurement of the median nerve CSA from inlet to outlet similar to the "inching test" provides more information on anatomic changes. This US finding has positive correlation with NCS severity and the duration of CTS clinical symptom. A combination of NCS and US studies, especially the 8-point measurement, may have a higher positive rate than NCS alone for diagnosing CTS
The authors declare that they have no competing interests.
All authors have read and approved the submitted manuscript.
SFC contributed to the conception and design, data acquisition and analysis, and drafting and revision of the manuscript; CHL, CRH, YCC, NWT, and CCC contributed to the conception and design, and clinical data analysis; and WNC contributed to the conception and design, data analysis, and critical revision and final approval of the manuscript.
The pre-publication history for this paper can be accessed here:
|Phalen GS,The carpal-tunnel syndrome. Clinical evaluation of 598 handsClin Ortho Relat ResYear: 1972832940|
|Jablecki CK,Andary MT,Floeter RG,Miller CA,Quartly CA,Vennix MJ,Wilson JR,American Association of Electro-diagnostic Medicine; American Academy of Neurology; American Academy of Physical Medicine and RehabilitationPractice parameter; Electro-diagnostic studies in carpal tunnel syndrome. Report of the American Association of Electro-diagnostic Medicine, American Academy of Neurology, and the American Academy of Physical Medicine and RehabilitationNeurologyYear: 2002581589159212058083|
|Hobson-Webb LD,Massey JM,Juel VC,Sanders DB,The ultrasonographic wrist-to-forearm median nerve area ratio in carpal tunnel syndromeClinNeurophysiolYear: 200811913531357|
|Kimura J,The carpal tunnel syndrome: localization of conduction abnormalities within the distal segment of median nerveBrainYear: 197910261963510.1093/brain/102.3.619497808|
|Wong SM,Griffith JF,Hui ACF,Lo SK,Fu M,Wong KS,Carpal tunnel srndrome: diagnostic usefulness of ultrasonographyRadiologyYear: 2004232939910.1148/radiol.232103007115155897|
|Ziswiler HR,Reichenbach S,Vogelin E,Bachmann LM,Villiger PM,Juni P,Diagnostic value of sonography in patients with suspected carpal tunnel syndrome: a prospective studyArthritis RheumYear: 20055230431110.1002/art.2072315641050|
|Beekman R,Visser LH,Sonography in the diagnosis of carpal tunnel syndrome: a critical review of the literatureMuscle NerveYear: 200327263310.1002/mus.1022712508291|
|Koyuncuoglu HR,Kutluhan S,Oyar O,Guler K,Ozden A,The value of ultrasonographic measurement in carpal tunnel syndrome in patients with negative electro-diagnostic testsEur J RadiolYear: 20055636536910.1016/j.ejrad.2005.05.01315994046|
|Mondelli M,Filippou G,Gallo A,Frediani B,Diagnostic utility of ultrasonography versus nerve conduction studies in mild carpal tunnel syndromeArthritis RheumYear: 20085935736610.1002/art.2331718311762|
|Padua L,Pazzaglia C,Caliandro P,Granata G,Foschini M,Briani C,Martinoli C,Carpal tunnel syndrome: ultrasound, neurophysiology, clinical and patient-oriented assessmentClin NeurophysiolYear: 20081192064206910.1016/j.clinph.2008.05.00418620908|
|Practice parameter for carpal tunnel syndrome (summary statement)Report of the Quality Standards Subcommittee of the American Academy of NeurologyNeurologyYear: 199343240624098232968|
|You H,Simmons Z,Freivalds A,Kothari MJ,Naidu SH,Relationships between clinical symptom severity scales and nerve conduction measures in CTSMuscle NerveYear: 19992249750110.1002/(SICI)1097-4598(199904)22:4<497::AID-MUS11>3.0.CO;2-T10204785|
|Jackson DA,Clifford JC,Electro-diagnosis of mild carpal tunnel syndromeArch Phys Med RehabilYear: 1989701992042923541|
|Uncini A,Lange DJ,Solomon M,Soliven B,Meer J,Lovelace RE,Ring finger testing in CTS: a comparative study of diagnostic utilityMuscle NerveYear: 19891273574110.1002/mus.8801209062641997|
|Walters RJL,Murray NMF,Trans-carpal motor conduction velocity in carpal tunnel syndromeMuscle NerveYear: 20012496696810.1002/mus.109611410926|
|Nathan PA,Meadows KD,Doyle LS,Sensory segmental latency values of the median nerve for a population of normal individualsArch Phys Med RehabilYear: 1988694995013389989|
|Padua L,LoMonaco M,Gregori B,Valente EM,Padua R,Tonali P,Neuro-physiologic classification and sensitivity in 500 CTS handsActa Neurol ScandYear: 1997962112179325471|
|Kuo MH,Leong CP,Cheng YF,Chang HW,Static wrist position associated with least median nerve compression: sonographic evaluationAm J Phys Med RehabilYear: 20018025626010.1097/00002060-200104000-0000411277131|
|Rahmani M,Ghasemi Esfe AR,Bozorg SM,Mazloumi M,Khalilzadeh O,Kahnouji H,The ultrasonographic correlates of carpal tunnel syndrome in patients with normal electro-diagnostic testsRadiol MedYear: 201111648949610.1007/s11547-011-0632-621293941|
|Lee CH,Kim TK,Yoon ES,Dhong ES,Correlation of high-resolution ultrasonographic findings with the clinical symptoms and electro-diagnostic data in carpal tunnel syndromeAnn Plast SurYear: 200554202310.1097/01.sap.0000141942.27182.55|
|Seror P,Sensitivity of the various tests for diagnosis of carpal tunnel syndromeJ Hand Surg BrYear: 19941972572810.1016/0266-7681(94)90245-37706874|
|Preston DC,Katirji B et alCompressive and entrapment neuropathies of the upper extremityNeuromuscular Disorders in Clinical PracticeYear: 2002Boston: Butterworth-Heinemann744773|
|Witt JC,Hentz JG,Stevens JC,Carpal tunnel syndrome with normal nerve conduction studiesMuscle NerveYear: 20042951552210.1002/mus.2001915052616|
|Karadag YS,Karadag O,Cicekli E,Ozturk S,Kiraz S,Ozbakir S,Filippucci E,Grassi W,Severity of carpal tunnel syndrome assessed with high frequency ultrasonographyRheumatol IntYear: 20103076176510.1007/s00296-009-1061-x19593567|
|Mohammadi A,Afshar A,Etemadi A,Masoudi S,Baghizadeh A,Diagnostic value of cross-sectional area of median nerve in grading severity of carpal tunnel syndromeArch Iran MedYear: 20101351652121039008|
|Visser LH,Smidt MH,Lee ML,High-resolution sonography versus EMG in the diagnosis of carpal tunnel syndromeJ Neurol Neurosurg PsychiatryYear: 200879636710.1136/jnnp.2007.11533717470471|
|Impink BG,Gagnon D,Collinger JL,Boninger ML,Repeatability of ultrasonographic median nerve measuresMuscle NerveYear: 20104176777310.1002/mus.2161920513104|
|Kimura J,Principles and pitfalls of nerve conduction studiesAnn NeurolYear: 19841641542910.1002/ana.4101604026093680|
|Geiringer SR,Inching Techniques are of limited usageMuscle NerveYear: 1998211557156110.1002/(SICI)1097-4598(199811)21:11<1557::AID-MUS32>3.0.CO;2-V9771688|
|Claes F,Meulstee J,Claessen-Oude Luttikhuis TT,Huygen PL,Verhagen WI,Usefulness of additional measurements of the median nerve with ultrasonographyNeurol SciYear: 20103172172510.1007/s10072-010-0258-920429021|
|Rha DW,Im SH,Kim SK,Chang WH,Kim KJ,Lee SC,Median nerve conduction study through the carpal tunnel using segmental nerve length measured by ultrasonographic and conventional tape methodArch Phys Med RehabilYear: 2011921610.1016/j.apmr.2010.09.01221187199|
Basic information of the control participants and the patients with NCS negative "CTS" hands
|"A-hands" (n = 50)||NCS negative "CTS hands" (n = 32)||p value|
|Sex||14 hands in man/36 hands in woman||4 hands in man/28 hands in woman||0.100|
|Age (yr)||44.2 ± 9.8 (46, 25-68)||48.6 ± 11.9 (49, 27-73)||0.135|
|BH (cm)||163 ± 7.2 (163, 148-174)||159 ± 6.9 (157.5, 150-177)||0.004*|
|BW (kg)||61.0 ± 8.1 (60, 46-76)||59.6 ± 10.8 (56, 46-86)||0.282|
|BMI||22.8 ± 3.0 (22.7, 17.5-28.3)||23.6 ± 4.4 (22.9, 17.5-35.3)||0.711|
Abbreviations: A-hands, asymptomatic hands; CTS, carpal tunnel syndrome; NCS, nerve conduction study; BH, body heigh; BW, body weight; BMI, body mass index; Mean ± standard deviation (Median, minimum-maximus);
*p < 0.01 by Mann-Whitney U test
Comparison of CSAs measured at the 8-point of the A-hands and NCS negative CTS-hands
|CSAs||p value||Cut-off values of CSA||Sensitivity||Specificity|
|A-hands (n = 50)||NCS negative CTS-hands(n = 32)|
|i4||11.8 ± 2.4 (11, 8-19)||14.3 ± 4.6 (13, 7-28)||0.003*||12.5||0.688||0.720|
|i3||11.5 ± 2.3 (11, 8-19)||14.0 ± 4.3 (13, 8-28)||0.001*||12.5||0.688||0.760|
|i2||10.9 ± 1.9 (11, 8-16)||11.9 ± 2.1 (12, 8-17)||0.033*||11.5||0.563||0.660|
|I1||10.7 ± 1.7 (10.5, 8-15)||12.2 ± 2.7 (11.1, 7-20)||0.006*||11.1||0.500||0.680|
|w||10.7 ± 2.0 (10.5, 7-17)||12.2 ± 2.9 (12, 7-22)||0.002*||11.5||0.594||0.760|
|o1||10.1 ± 2.2 (10, 6-16)||11.0 ± 2.3 (10, 7-16)||0.082||10.5||0.469||0.600|
|o2||10.2 ± 2.1 (10, 7-17)||10.6 ± 2.0 (10.5, 6-15)||0.164||10.5||0.500||0.600|
|o3||9.4 ± 1.9 (9, 6-15)||10.6 ± 2.7 (11, 5-17)||0.031*||10.1||0.563||0.740|
Abbreviations: CSAs, cross-section areas; A-hands, asymptomatic hands; CTS-hands, carpal tunnel syndrome hands; NCS, nerve conduction study
Markers of the 8-point: i4, i3, i2, i1, w, o1, o2, and o3 Unit of CSA = mm2
*p < 0.05, by Mann-Whitney U test
CSAs measured at the 8-point of the CTS-hands with different NCS severities (n = 212)
(n = 32)
(n = 40)
(n = 43)
(n = 85)
(n = 10)
(n = 2)
|i4||14.3 ± 4.6 (7-28)||15.4 ± 4.7 (8-30)||17.3 ± 5.3 (8-34)*||19.8 ± 6.8 (8.9-41)*||17.3 ± 8.9 (8-40.8)||15.5 ± 3.5 (13-18)|
|i3||14.0 ± 4.3 (8-28)||15.0 ± 4.6 (8-27)||16.0 ± 4.6 (8-26)||18.4 ± 5.9 (8.9-42)*||17.3 ± 8.9 (8-40.8)||15.5 ± 3.5 (16-22)|
|i2||11.9 ± 2.1 (8-17)||12.0 ± 3.0 (7-21)||12.3 ± 2.4 (6-18)||13.8 ± 3.8 (7-29)||13.4 ± 4.7 (8-23.6)||17.0 ± 1.4 (16-18)|
|i1||12.2 ± 2.7 (7-20)||12.6 ± 3.1 (7-20)||14.8 ± 4.9 (8-28)||15.4 ± 5.0 (7-34.4)*||16.7 ± 6.7(11.1-34.3)*||14.5 ± 7.8 (9-20)|
|w||12.2 ± 2.9 (7-22)||12.9 ± 3.4 (7-22)||14.6 ± 3.4 (7-23) *||17.5 ± 5.8 (9-40.4)*||16.0 ± 5.7 (8.9-26)||26.5 ± 9.2 (20-33)*|
|o1||11.0 ± 2.3 (7-16)||12.2 ± 2.8 (8-20.7)||12.9 ± 3.0 (8-20) *||14.3 ± 3.2(8.7-27.4)*||13.9 ± 4.5 (7-20.3)||22.5 ± 4.9 (19-26)*|
|o2||10.6 ± 2.0 (6-15)||11.6 ± 2.6 (8-21)||12.0 ± 2.2 (8-17) *||12.8 ± 2.7 (7-21.3)*||13.9 ± 3.6 (9-19.9)||17.0 ± 0.0 (17-17)*|
|o3||10.6 ± 2.7 (5-17)||10.9 ± 2.0 (7-15)||11.2 ± 1.9 (7-15)||11.5 ± 2.5 (6-19)||12.0 ± 2.2 (9-16)||19.0 ± 0.0 (19-19)*|
Abbreviations: CSAs, cross-section areas; CTS-hands, carpal tunnel syndrome hands; NCS, nerve conduction study Markers of the 8-point: i4, i3, i2, i1, w, o1, o2, and o3
Unit of CSA = mm2
*p < 0.01, by Mann-Whitney U test (comparing CSAs of the minimal to extreme groups with the negative group)
Distributions of the positive sites in inching test of all tested hands
|N (%)||119||37 (25.9)||55 (38.5)||6 (4.2)||10 (7.0)||8 (5.6)||2 (1.4)||0 (0)||25 (17.4)||262|
Markers of the 8-point: i4, i3, i2, i1, W, o1, o2, and o3 "double" means more than two sites existed
Comparison of CSAs at the 8-points among the two most frequent positive sites and the negative site in the inching test
|none (n = 119)||i4-i3 (n = 37)||i3-i2 (n = 55)|
|i4||13.9 ± 4.8(7-40.8)||19.5 ± 6.9 (9-37)*||19.0 ± 6.9 (8-41)*|
|i3||13.6 ± 4.8 (8-40.8)||17.4 ± 5.0 (8-32) *||17.9 ± 6.3 (8-42)*|
|i2||12.0 ± 3.1 (8-29)||12.4 ± 3.1 (6-19)||13.2 ± 3.4 (8-25)|
|i1||12.4 ± 4.1 (7-34.4)||13.6 ± 4.5 (7-31)||14.6 ± 4.3 (7.4-25)*|
|w||12.5 ± 4.0 (7-31)||14.5 ± 4.6 (7-27)||15.6 ± 4.9 (7-33)*|
|o1||11.3 ± 2.8 (6-20.7)||13.1 ± 2.9 (9-20)||13.6 ± 3.6 (8-26)*|
|o2||11.0 ± 2.4 (6-18.5)||12.2 ± 2.4 (8-18)||12.8 ± 2.7 (8-21.3)*|
|o3||10.5 ± 2.6 (5-19)||10.5 ± 2.3 (6-16)||11.8 ± 2.4 (8-19)*|
Note: CSA, cross-section area; none, no conductive delay >0.4 ms in median inching test in centimeter across the carpal tunnel; i4-i3, conductive delay >0.4 ms in inching test between 4 cm and 3 cm distal to the wrist crease; i3-i2, conductive delay >0.4 ms in inching test between 3 cm and 2 cm distal to the wrist crease
Markers of the 8-point: i4, i3, i2, i1, w, o1, o2, and o3
i4-i3 and i3-i2: the difference of latency measured between locations of i4 and i3, and i3 and i2 in the inching test
Unit of CSA = mm2
*p < 0.05 in comparing the two most frequent positive sites and the negative one in inching test using analysis of variance (ANOVA) followed by Scheffe's multiple comparison procedure
Comparison of CSAs at the 8-point of the 'A-hands' with the "CTS-hands" of different symptom durations
|(n = 50)||1 month(n = 12)||> 1 month and 12 months (n = 82)||>12 months (n = 118)|
|i4||11.8 ± 2.4 (8-19)||14.1 ± 4.7 (8-24)||16.6 ± 5.1 (7-34)*||18.5 ± 6.9 (8-41)*|
|i3||11.5 ± 2.3 (8-19)||12.7 ± 2.9 (8-17)||16.0 ± 5.0 (8-28) *||17.3 ± 6.0 (8-42)*,#|
|i2||10.9 ± 1.9 (8-16)||11.2 ± 2.6 (7-17)||12.8 ± 2.8 (7-20) *||13.1 ± 3.7 (6-29)*|
|i1||10.7 ± 1.7 (8-15)||12.8 ± 2.0 (10-16)||13.6 ± 4.1 (7-24) *||15.0 ± 5.1 (7-34.4)*|
|w||10.7 ± 2.0 (7-17)||11.7 ± 3.3 (7-18)||14.8 ± 5.2 (7-40.4) *||16.0 ± 5.2 (7-33)*#|
|o1||10.1 ± 2.2 ( 6-16)||11.2 ± 2.9 (7-16)||12.8 ± 3.2 (7-23) *||13.7 ± 3.4 (8-27.4)*|
|o2||10.2 ± 2.1 (7-17)||10.8 ± 2.0 (8-15)||11.6 ± 2.3 (6-19) *||12.7 ± 2.8 (7-21.3)*|
|o3||9.4 ± 1.9 (6-15)||10.5 ± 2.6 (7-17)||11.1 ± 2.2 (5-16) *||11.4 ± 2.6 (6-19)*|
Abbreviations: A-hand, asymptomatic hands; CTS-hands, carpal tunnel syndrome hand; CSAs, cross section areas Markers of the 8-point: i4, i3, i2, i1, w, o1, o2, and o3. Unit of CSA = mm2
*p < 0.05 (a comparison of CSAs of the 'A-hands' with the CSAs of the 'CTS-hands' of different symptom durations using analysis of variance (ANOVA) followed by Scheffe's multiple comparison procedure)
#p < 0.05 (a comparison of CSAs of the CTS-hands with <1 month duration with the CSAs of the 'CTS-hands' with >12 months duration using analysis of variance (ANOVA) followed by Scheffe's multiple comparison procedure)
Previous Document: The development of salty taste acceptance is related to dietary experience in human infants: a prosp...
Next Document: Genotype and cognitive phenotype of patients with tuberous sclerosis complex.